Pfizer's with an answer for kids covid 19 vaccines?

Sachin
According to a previous head of the US Food & Drug Administration, that Pfizer-BioNTech vaccination is anticipated to be approved for distribution among children aged 5 to 12 years by october 2021. (FDA). Only Pfizer has been given emergent use authorization for kids ages 12 and up of the 3 COVID-19 vaccinations presently used in the United States. Pfizer, Moderna, as well as Johnson & Johnson are all conducting clinical studies to determine the safety and effectiveness of their various vaccinations in kids below the age of 12.

The findings from Pfizer are scheduled to be released in September. FDA will be ready to accept Pfizer by mid-fall or first winter, according to Gottlieb. He went on to say that the choice would most likely be dependent on the country's COVID-19 status at the moment, as well as the necessity of immunization children.

Pfizer is currently undertaking studies for kids aged 1 to 2 years old, with findings due in November. According to the previous FDA director, about 300 children are hospitalised to hospitals having COVID-19 every day. Since schools resumed, he said, the prevalence of the virus among youngsters has risen dramatically. He recommended that schools begin evaluating kids twice a week and employ geographic separation to reduce intermingling between student groups.

Find Out More:

Related Articles: